What Referring Physicians Should Know: Avoiding the "Wait and See" Approach

A longstanding misconception in the broader medical community holds that alopecia areata is a self-limited condition that warrants watchful observation rather than active intervention. The origins of this perspective are historically understandable: for most of the disease's recorded medical history, no systemic therapies existed that reliably halted progression or restored meaningful amounts of hair. Dermatologists and generalists alike counseled patients to reduce stress, remain patient, and hope for spontaneous regrowth—not because the evidence supported this approach, but because the alternatives were limited, unpredictable, and offered no guarantee. The field has since changed fundamentally with the arrival of JAK inhibitors, yet the cultural inertia of "wait and see" has proven difficult to dislodge, particularly among clinicians who trained or practiced extensively before these agents became available.

The clinical evidence now clearly supports earlier treatment initiation. Disease progression in AA appears more amenable to reversal when systemic therapy is introduced before extensive and prolonged follicular injury accumulates. Patients who are advised to wait and monitor may arrive at the dermatologist months or years later with far greater scalp involvement, potentially having passed the window of best therapeutic response. Dermatologists managing AA should actively communicate this message to referring physicians: lower the threshold for referral, stop framing the consultation as elective or cosmetic, and recognize that counseling a patient to simply reduce stress—a behavior that cannot be reliably enacted on command-adds delay without benefit. Every visit in which a patient is told their hair will likely return on its own is a visit in which the window for optimal treatment response narrows further.

In this segment, Nader Aboul-Fettouh, MD, double board-certified dermatologist and fellowship-trained Mohs Micrographic Surgeon and founder and managing director of Blue Ribbon Dermatology in the Dallas area, discusses the most common referral-related misconception he encounters-the assumption that alopecia areata will self-resolve-and explains in direct clinical terms why that framing, while historically rooted in the absence of effective treatments, now actively undermines patient outcomes. He also describes the specific guidance he gives his own patients: to alert him immediately if new patches appear, if existing lesions are expanding rapidly, or if involvement is spreading to new body sites, because the pace and pattern of progression directly inform which therapeutic approach is most appropriate.